FDA Grants Priority Review to Idebenone for Leber Hereditary Optic Neuropathy
A rare disease, a rare chance. FDA fast-tracks idebenone for LHON. The U.S. Food and Drug Administration (FDA) doesn’t hand…
Outlook Therapeutics Requests Type A Meeting with FDA After Second Rejection of Wet AMD Drug Bevacizumab
The road to U.S. approval for ONS-5010 has been anything but smooth. Outlook Therapeutics (New Jersey, USA) is once again…
latest posts
